# Network Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/network-bio

- Industry: Biotechnology
- Headquarters: Palo Alto, US
- Website: www.network.bio
- Total disclosed funding: $50M
- Latest round: Series B (Aug 19, 2026)
- Investors on record: 6

## About

Established in 2022 and based in California, US, Network Bio is a healthcare AI company that builds generalizable AI models trained on large-scale patient tissue, blood sample, and clinical outcome data to support disease detection, biomarker discovery, and personalized medicine.

## Funding rounds

- Series B, Aug 19, 2026, $50M — Founders Fund, BlueCross BlueShield Venture Partners, Breyer Capital, Section 32, JSL Health Capital, Thiel Bio

## Investors

- Founders Fund (https://capitalatlas.ai/funds/founders-fund) — Series B
- BlueCross BlueShield Venture Partners (https://capitalatlas.ai/funds/bluecross-blueshield-venture-partners) — Series B
- Breyer Capital (https://capitalatlas.ai/funds/breyer-capital) — Series B
- Section 32 (https://capitalatlas.ai/funds/section-32) — Series B
- JSL Health Capital (https://capitalatlas.ai/funds/jsl-health-capital) — Series B
- Thiel Bio (https://capitalatlas.ai/funds/thiel-bio) — Series B